Stockscreener 앱 받기
20.98
1.13%
-0.24
시장 영업 전:
20.95
-0.03
-0.14%
Zai Lab Limited Adr 주식(ZLAB)의 최신 뉴스
Zai Lab (ZLAB) Expected to Announce Earnings on Thursday - MarketBeat
Zai Lab (NASDAQ: ZLAB, HKEX: 9688) details 2026 AGM votes on board, pay, 10% mandates - Stock Titan
BofAS Raises Zai Lab (09688.HK) TP to HKD18.6, Rating Neutral - AASTOCKS.com
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Zai Lab Showcases 54% Brain Metastases Response for ZL-1310 ADC in SCLC at AACR Investor Call - Yahoo Finance
Assessing Zai Lab (NasdaqGM:ZLAB) Valuation After Recent Share Price Momentum Shift - Sahm
Zai Lab (NASDAQ:ZLAB) Trading Down 5.2%Here's What Happened - MarketBeat
Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026 - BioSpace
Zai Lab Ltd (ADR) stock (CA98959U1084): Why Google Discover changes matter more now - AD HOC NEWS
Zai Lab Ltd stock (US98887Q1040): Is its China oncology focus strong enough to unlock new upside? - AD HOC NEWS
Zai Lab and Amgen Launch Clinical Trial for Lung Cancer Therapy - HarianBasis.co
Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer with Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas - Business Wire
Zai Lab (NASDAQ:ZLAB) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
[PRE 14A] Zai Lab Ltd Preliminary Proxy Statement - Stock Titan
Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas - GlobeNewswire Inc.
Assessing Zai Lab (NasdaqGM:ZLAB) Valuation After New Lung Cancer Trial Progress And Amgen Collaboration - Sahm
Zai Lab (NASDAQ:ZLAB) Insider Rafael Amado Sells 2,739 Shares - MarketBeat
Zai Lab (ZLAB) officer auto-sells ADSs to cover RSU tax obligations - Stock Titan
Zai Lab (NASDAQ: ZLAB) CLO auto-sells 1,224 ADSs to cover RSU tax - Stock Titan
Zai Lab (ZLAB) CEO records small ADS sale to cover tax on RSUs - Stock Titan
Zai Lab (NASDAQ: ZLAB) CFO sells 853 ADSs in tax-related RSU vesting - Stock Titan
Tax-driven Zai Lab (ZLAB) ADS sale reported for company executive - Stock Titan
Zai Lab Ltd (ADR) stock: What investors need to know now - AD HOC NEWS
Zai Lab (NASDAQ: ZLAB) reports 5.74M ADS (57.4M ordinary shares) - Stock Titan
ZLAB (NASDAQ: ZLAB) insider files Form 144 showing 11,580 ADS sales - Stock Titan
[144] Zai Lab Ltd SEC Filing - Stock Titan
ZLAB (NASDAQ: ZLAB) Form 144 shows Rafael Amado sold ADS in Mar–Apr 2026 - Stock Titan
ZLAB (NASDAQ: ZLAB) notices proposed sale of 853 ADS; prior transfers listed - Stock Titan
Yajing Chen Sells 5,199 Shares of Zai Lab (NASDAQ:ZLAB) Stock - defenseworld.net
Zai Lab Limited And Amgen Inc. Collaborate To Advance DLL3 Targeted Combination Therapy In Small Cell Lung Cancer - BioPharma APAC
Zai Lab Limited (9688.HK) stock price, news, quote and history - Yahoo Finance Singapore
Zai Lab Limited (ZLAB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Zai Lab Limited (ZLAB) stock price, news, quote and history - uk.finance.yahoo.com
Revenue per share of Zai Lab Ltd. Sponsored ADR – FWB:1ZL - TradingView
Zai Lab (NASDAQ:ZLAB) CFO Sells $106,007.61 in Stock - MarketBeat
Zai Lab (NASDAQ:ZLAB) Insider Sells $196,029.46 in Stock - MarketBeat
Zai Lab (NASDAQ:ZLAB) CEO Ying Du Sells 5,576 Shares - MarketBeat
Rafael Amado Sells 9,910 Shares of Zai Lab (NASDAQ:ZLAB) Stock - MarketBeat
Zai Lab (ZLAB) CEO nets shares after RSU vesting and tax sale - Stock Titan
Zai Lab (ZLAB) CFO exercises RSUs, automatic ADS sale for taxes - Stock Titan
Zai Lab (ZLAB) executive sells ADSs to cover tax after RSU vest - Stock Titan
Zai Lab Ltd (ADR) stock: China's biotech powerhouse eyes global gains - AD HOC NEWS
Zai Lab (ZLAB) CLO nets ADSs after RSU vesting and tax sale - Stock Titan
Rafael Amado reports ADS sales for ZLAB (NASDAQ: ZLAB) - Stock Titan
9,614 ADS tied to vesting listed by ZLAB (NASDAQ: ZLAB) with Fidelity broker - Stock Titan
Insider sells ZLAB (NASDAQ: ZLAB) ADS — Form 144 lists 4,194 shares - Stock Titan
Affiliate sale notice: ZLAB (NASDAQ: ZLAB) up to 5,199 ADS - Stock Titan
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy - BioSpace
Zai Lab (NASDAQ:ZLAB) Trading 9.5% HigherStill a Buy? - MarketBeat
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Hesai Group Sponsored ADR (NASDAQ:HSAI) Given Consensus Rating of “Buy” by Brokerages - Defense World
Hennes & Mauritz AB (OTCMKTS:HNNMY) Given Average Recommendation of “Hold” by Brokerages - Defense World
HBT Financial, Inc. (NASDAQ:HBT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
KeyCorp (NYSE:KEY) Price Target Cut to $24.00 by Analysts at Morgan Stanley - Defense World
0.14%
0.48%
자본화:
|
볼륨(24시간):